Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Emmer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Chemical Neuroanatomy|October 9, 2021
Surfactant protein C is associated with perineuronal nets and shows age-dependent changes of brain content and hippocampal deposits in wildtype and 3xTg miceStefan Schob, Joana Puchta, Karsten Winter, et al.
Molecular Neurobiology|July 23, 2018
Localization, Occurrence, and CSF Changes of SP-G, a New Surface Active Protein with Assumable Immunoregulatory Functions in the CNSMatthias Krause, Nicole Peukert, Wolfgang Härtig, et al.
Journal of Neuromuscular Diseases|June 13, 2022
GFPT1-Associated Congenital Myasthenic Syndrome Mimicking a Glycogen Storage Disease - Diagnostic Pitfalls in Myopathology Solved by Next-Generation-SequencingAlexander Mensch, Isabell Cordts, Leila Scholle, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Chemical Neuroanatomy|October 9, 2021
Surfactant protein C is associated with perineuronal nets and shows age-dependent changes of brain content and hippocampal deposits in wildtype and 3xTg miceStefan Schob, Joana Puchta, Karsten Winter, et al.
Molecular Neurobiology|July 23, 2018
Localization, Occurrence, and CSF Changes of SP-G, a New Surface Active Protein with Assumable Immunoregulatory Functions in the CNSMatthias Krause, Nicole Peukert, Wolfgang Härtig, et al.
Journal of Neuromuscular Diseases|June 13, 2022
GFPT1-Associated Congenital Myasthenic Syndrome Mimicking a Glycogen Storage Disease - Diagnostic Pitfalls in Myopathology Solved by Next-Generation-SequencingAlexander Mensch, Isabell Cordts, Leila Scholle, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 4